首页> 外文期刊>Journal of Medicinal Chemistry >Structure-Activity Study of the ORL1 Antagonist Ac-Arg-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH_2
【24h】

Structure-Activity Study of the ORL1 Antagonist Ac-Arg-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH_2

机译:ORL1拮抗剂Ac-Arg-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH_2的结构活性研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The structure-activity requirements of the ORL1 antagonist Ac-Arg-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH_2 4 were investigated by varying the position, structure, and charge of the Arg residues. Attempts to abridge the peptide by removal of the Arg, D-Cha, and D-p-ClPhe residues abolished affinity for the ORL1 receptor, whereas deletion of the acetamido N-terminus maintained receptor affinity and selectivity. This series of analogues has provided an improved potent and selective ORL1 receptor antagonist, Ac-Cit-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH_2.
机译:通过改变Arg残基的位置,结构和电荷,研究了ORL1拮抗剂Ac-Arg-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH_2 4的结构活性要求。尝试通过去除Arg,D-Cha和D-p-ClPhe残基来缩短肽段,从而消除了对ORL1受体的亲和力,而乙酰胺基N末端的缺失则保持了受体的亲和力和选择性。该系列类似物提供了一种改良的有效ORL1受体拮抗剂,Ac-Cit-D-Cha-Qaa-D-Arg-D-p-ClPhe-NH_2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号